medigraphic.com
ISSN 1561-3119 (Electronic)

2020, Number 4

<< Back Next >>

Rev Cubana Pediatr 2020; 92 (4)

Clinical practice guidelines in biliary atresia

Villamil MR, Pi OAJ, Ramírez GA, Pérez DA, Betancourt BD, Silverio GC, Cobas TY

Language: Spanish
References: 28
Page: 1-16
PDF size: 552.46 Kb.


ABSTRACT

Based on the best scientific evidence available, it is presented the clinical practice guidelines on biliary atresia. This disease is defined as a progressive obstruction of the intra and/or extrahepatic bile ducts in newborns and young infants, causing severe cholestatic jaundice and cirrhosis of the liver. It is a rare disease of unknown etiology, with a higher incidence in Asian countries. It is clinically expressed by obstructive jaundice, acholia, choluria and hepatosplenomegaly. Laboratory tests show a direct hyperbilirubin and elevated liver enzymes, and in our hospital, the diagnosis is confirmed by a cholangiography, usually during a laparoscopy procedure. It has surgical treatment and it involves a Kasai portoenterostomy, with better results regarding biliary drainage if it is performed before 60 days of life, as well as liver transplant. This condition has a progressive course towards liver cirrhosis in early stages of life, mainly if the diagnosis and surgical treatment are not made timely, with implications for the survival and quality of life of these patients. Therefore, early referral of the patient with suspected biliary atresia to a specialized center is the cornerstone of the medical attitude. This clinical practice guidelines aims to offer standardized technical tools to improve the outcome for patients with this disease, as well as to contribute to teaching and research.


REFERENCES

  1. DynaMed Plus. EBSCO Information Services. Biliary atresia. Ipswich (MA): DInamed; 2018 [acceso 01/06/2019]. Disponible en: Disponible en: http://www.dynamed.com/topics/dmp~AN~T116791/Biliary-atresia#References

  2. Gu Y-H, Yokoyama K, Mizuta K, Tsuchioka T, Kudo T, Sasaki H, et al. Stool color card screening for early detection of biliary atresia and long-term native liver survival: a 19-year cohort study in Japan. J Pediatr. 2015;166(4):897-902.e1.

  3. Silverio García CE, Pérez Valencia DC, Villamil Martínez R, Sosa Palacios O, Cobas Torres Y. Patrón clínico y epidemiológico de la atresia de vías biliares en Cuba. Rev Cubana Pediatr. 2018 [acceso 03/06/ 2019];90(4). Disponible en: http://scielo.sld.cu/scielo.php?script=sci_abstract&pid=S0034-75312018000400004&lng=es&nrm=iso&tlng=es

  4. Asai A, Miethke A, Bezerra JA. Pathogenesis of biliary atresia: defining biology to understand clinical phenotypes. Nat Rev Gastroenterol Hepatol. 2015;12(6):342-52.

  5. Davenport M. Adjuvant therapy in biliary atresia: hopelessly optimistic or potential for change? Pediatr Surg Int. 2017;33(12):1263-73.

  6. di Pasquo E, Kuleva M, Rousseau A, Vitucci A, Sonigo P, Chardot C, et al. Non-visualization of fetal gallbladder (NVFGB) by ultrasound in second trimester of pregnancy: a systematic review of the literature on postnatal outcome. Ultrasound Obstet Gynecol. 2019;54:582-8.

  7. Liu X, Peng X, Huang Y, Shu C, Liu P, Xie W, et al. Design and validation of a noninvasive diagnostic criteria for biliary atresia in infants based on the STROBE compliant. Medicine (Baltimore). 2019 [acceso 01/06/ 2019];98(6):e13837. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6380858/

  8. Robie DK, Overfelt SR, Xie L. Differentiating biliary atresia from other causes of cholestatic jaundice. Am Surg. 2014;80(9):827-31.

  9. Nakamura H, Yamataka A. Non-invasive and accurate diagnostic system for biliary atresia. EBio Med. 2018;36:16-7.

  10. Dong R, Jiang J, Zhang S, Shen Z, Chen G, Huang Y, et al. Development and Validation of Novel Diagnostic Models for Biliary Atresia in a Large Cohort of Chinese Patients. EBio Med. 2018;34:223-30.

  11. Choochuen P, Kritsaneepaiboon S, Charoonratana V, Sangkhathat S. Is "gallbladder length-to-width ratio" useful in diagnosing biliary atresia? J Pediatr Surg. 2019;54(9):1946-52.

  12. Yoon HM, Suh CH, Kim JR, Lee JS, Jung AY, Cho YA. Diagnostic Performance of Sonographic Features in Patients With Biliary Atresia: A Systematic Review and Meta-analysis. J Ultrasound Med. 2017;36(10):2027-38.

  13. Schooler GR, Mavis A. Cystic biliary atresia: A distinct clinical entity that may mimic choledochal cyst. Radiol Case Rep. 2018;13(2):415-8.

  14. Kianifar HR, Tehranian S, Shojaei P, Adinehpoor Z, Sadeghi R, Kakhki VRD, et al. Accuracy of hepatobiliaryscintigraphy for differentiation of neonatal hepatitis from biliary atresia: systematic review and meta-analysis of the literature. Pediatr Radiol. 2013;43(8):905-19.

  15. Malik D, Khan SH, Ali SW, Rather TA, Pakala R, Hassan MU, et al. Comparison of phenobarbitone and ursodeoxycholic acid in drug-augmented hepatobiliaryscintigraphy for excluding the diagnosis of obstructive cholestasis in neonatal cholestasis syndrome. Nucl Med Commun. 2015;36(8):827-32.

  16. Chan KWE, Lee KH, Wong HYV, Tsui SYB, Mou JWC, Tam YHP. Ten-Year Native Liver Survival Rate After Laparoscopic and Open Kasai Portoenterostomy for Biliary Atresia. J Laparoendosc Adv Surg Tech A. 2019;29(1):121-5.

  17. Hussain MH, Alizai N, Patel B. Outcomes of laparoscopic Kasai portoenterostomy for biliary atresia: A systematic review. J Pediatr Surg. 2017;52(2):264-7.

  18. Sun X, Diao M, Wu X, Cheng W, Ye M, Li L. A prospective study comparing laparoscopic and conventional Kasai portoenterostomy in children with biliary atresia. J Pediatr Surg. 2016;51(3):374-378.

  19. Decharun K, Leys CM, West KW, Finnell SME. Prophylactic Antibiotics for Prevention of Cholangitis in Patients With Biliary Atresia Status Post-Kasai Portoenterostomy: A Systematic Review. Clin Pediatr (Phil). 2016;55(1):66-72.

  20. Ruuska SM, Lääperi MT, Hukkinen M, Jalanko H, Kolho K-L, Pakarinen MP. Growth of children with biliary atresia living with native livers: impact of corticoid therapy after portoenterostomy. Eur J Pediatr. 2019;178(3):341-9.

  21. Alonso EM, Ye W, Hawthorne K, Venkat V, Loomes KM, Mack CL, et al. Impact of Steroid Therapy on Early Growth in Infants with Biliary Atresia: The Multicenter Steroids in Biliary Atresia Randomized Trial. J Pediatr. 2018;202:179-185.e4.

  22. Bezerra JA, Spino C, Magee JC, Shneider BL, Rosenthal P, Wang KS, et al. Use of corticosteroids after hepatoportoenterostomy for bile drainage in infants with biliary atresia: the START randomized clinical trial. JAMA. 2014;311(17):1750-9.

  23. Qiu J-L, Shao M-Y, Xie W-F, Li Y, Yang H-D, Niu M-M, et al. Effect of combined ursodeoxycholic acid and glucocorticoid on the outcome of Kasai procedure. Medicine (Baltimore). 2018 acceso 01/06/ 2019;97(35):e12005. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6393119/

  24. Wang Z, Chen Y, Peng C, Pang W, Zhang T, Wu D, et al. Five-year native liver survival analysis in biliary atresia from a single large Chinese center: The death/liver transplantation hazard change and the importance of rapid early clearance of jaundice. J Pediatr Surg. 2018;54(8):1680.

  25. Nakajima H, Koga H, Okawada M, Nakamura H, Lane GJ, Yamataka A. Does time taken to achieve jaundice-clearance influence survival of the native liver in post-Kasai biliary atresia? World J Pediatr. 2018;14(2):191-6.

  26. Ihn K, Ho IG, Chang EY, Han SJ. Correlation between gamma-glutamyltranspeptidase activity and outcomes after Kasai portoenterostomy for biliary atresia. J Pediatr Surg. 2018;53(3):461-7.

  27. Harpavat S, Heubi JE, Karpe SJ, Ng VL, Setchell KDR, Shneider BL, et al. Prognostic value of serum bile acids after Kasai portoenterostomy in biliary atresia. Hepatology (Baltimore, MD). 2018;68:85A-86A.

  28. Davenport M, Ong E, Sharif K, Alizai N, McClean P, Hadzic N, et al. Biliary atresia in England and Wales: results of centralization and new benchmark. J Pediatr Surg. 2011;46(9):1689-94.




2020     |     www.medigraphic.com